Washington, Apr 15 : In a breakthrough study, a group of patients with type 1 diabetes were freed from daily insulin injections for up to four years following a transplant using their own stem cells.
According to the study in the April 15 issue of JAMA, a theme issue on diabetes, majority of patients with type 1 diabetes who underwent a certain type of stem cell transplantation became insulin free with good glycemic control, and also increased C-peptide levels, an indirect measure of beta-cell function.
Richard K. Burt, M. D., of the Northwestern University Feinberg School of Medicine, Chicago, presented the findings of the study at a JAMA media briefing at the National Press Club in Washington, D. C.